Elanco Animal Health Inc (NYSE: ELAN) kicked off on Monday, down -0.07% from the previous trading day, before settling in for the closing price of $14.29. Over the past 52 weeks, ELAN has traded in a range of $8.02-$15.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 29.95% over the last five years. While this was happening, its average annual earnings per share was recorded -7.67%. With a float of $491.95 million, this company’s outstanding shares have now reached $496.46 million.
The firm has a total of 9450 workers. Let’s measure their productivity. In terms of profitability, gross margin is 45.99%, operating margin of 5.4%, and the pretax margin is 12.11%.
Elanco Animal Health Inc (ELAN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Elanco Animal Health Inc is 0.95%, while institutional ownership is 100.90%. The most recent insider transaction that took place on Mar 07 ’25, was worth 109,000. In this transaction Director of this company bought 10,000 shares at a rate of $10.90, taking the stock ownership to the 101,459 shares. Before that another transaction happened on Mar 11 ’25, when Company’s Director bought 10,000 for $10.20, making the entire transaction worth $102,000. This insider now owns 111,459 shares in total.
Elanco Animal Health Inc (ELAN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -7.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.04% during the next five years compared to 29.95% growth over the previous five years of trading.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Take a look at Elanco Animal Health Inc’s (ELAN) current performance indicators. Last quarter, stock had a quick ratio of 1.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.60. Likewise, its price to free cash flow for the trailing twelve months is 20.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.75, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 0.95 in one year’s time.
Technical Analysis of Elanco Animal Health Inc (ELAN)
Analysing the last 5-days average volume posted by the [Elanco Animal Health Inc, ELAN], we can find that recorded value of 5.72 million was better than the volume posted last year of 5.45 million. As of the previous 9 days, the stock’s Stochastic %D was 88.50%.
During the past 100 days, Elanco Animal Health Inc’s (ELAN) raw stochastic average was set at 96.46%, which indicates a significant increase from 83.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.60% in the past 14 days, which was lower than the 60.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.31, while its 200-day Moving Average is $12.21. Now, the first resistance to watch is $14.51. This is followed by the second major resistance level at $14.75. The third major resistance level sits at $15.00. If the price goes on to break the first support level at $14.03, it is likely to go to the next support level at $13.78. Now, if the price goes above the second support level, the third support stands at $13.54.
Elanco Animal Health Inc (NYSE: ELAN) Key Stats
The company with the Market Capitalisation of 7.09 billion has total of 496,646K Shares Outstanding. Its annual sales at the moment are 4,439 M in contrast with the sum of 338,000 K annual income. Company’s last quarter sales were recorded 1,193 M and last quarter income was 67,000 K.
